)
Medicine Man Technologies (SHWZ) investor relations material
Medicine Man Technologies Q2 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Gained market share in Colorado and New Mexico, outperforming local markets year-over-year and quarter-over-quarter.
Achieved sequential quarterly growth across key financial metrics in Q2 2024, driven by growth and restructuring initiatives.
Focused on consumer needs, retail experience, and loyalty programs to drive customer acquisition and retention.
Implemented restructuring initiatives, including store closures and operational streamlining, to enhance profitability.
Financial highlights
Q2 2024 revenue increased 2% year-over-year to $43.2 million, primarily from new stores.
Gross profit was $19 million (44% margin), down from $23 million (54.4%) last year due to pricing pressure and product mix.
Operating expenses rose to $21.8 million from $18.1 million, driven by SG&A for five new stores and non-recurring professional fees.
Loss from operations was $2.7 million, compared to $5 million income last year; net loss widened to $13.9 million from $6.6 million.
Adjusted EBITDA was $9 million (21% margin), down from $13.8 million (33%) last year.
Cash and equivalents at $12.3 million as of June 30, 2024; total debt at $163.4 million.
Outlook and guidance
Expect continued growth and improved profitability in the second half of 2024.
Ongoing focus on refining retail strategy and driving operating efficiencies across retail, cultivation, and manufacturing.
Anticipate net new store growth in New Mexico to turn negative due to increased regulatory enforcement and closures.
Recent debt restructuring provides financial flexibility for strategic growth.
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)